An open label one arm clinical trial to assess the efficacy of intralesional tranexamic acid in the treatment of melasma patients from eastern India
17:00
Sessões recomendadas
Simpósio da indústria
SUISSELLE SA Symposium - ECM-driven regenerative protocols to support healthy aging
Simpósio da indústria
UNILEVER Symposium - Introducing GLYCOXOME™, the next-generation biostimulator: A precursor technology for superior sun-induced melasma and barrier repair